دورية أكاديمية
أعرض في EDS

Neuroimaging Markers for Determining Former American Football Players at Risk for Alzheimer's Disease.

التفاصيل البيبلوغرافية
العنوان: Neuroimaging Markers for Determining Former American Football Players at Risk for Alzheimer's Disease.
المؤلفون: Baragi VM; Center for Neurological Studies, Dearborn, Michigan, USA., Gattu R; Center for Neurological Studies, Dearborn, Michigan, USA., Trifan G; University of Illinois, Chicago, Illinois, USA., Woodard JL; Wayne State University, Detroit, Michigan, USA., Meyers K; Wayne State University, Detroit, Michigan, USA., Halstead TS; Wayne State University, Detroit, Michigan, USA., Hipple E; Subject Recruiter, Fenton, Michigan, USA., Haacke EM; HUH-MR Research/Radiology, Wayne State University/Detroit Receiving Hospital, Detroit, Michigan, USA., Benson RR; Center for Neurological Studies, Dearborn, Michigan, USA.
المصدر: Neurotrauma reports [Neurotrauma Rep] 2022 Sep 22; Vol. 3 (1), pp. 398-414. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101773091 Publication Model: eCollection Cited Medium: Internet ISSN: 2689-288X (Electronic) Linking ISSN: 2689288X NLM ISO Abbreviation: Neurotrauma Rep Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: New Rochelle, NY : Mary Ann Liebert, Inc., [2020]-
مستخلص: NFL players, by virtue of their exposure to traumatic brain injury (TBI), are at higher risk of developing dementia and Alzheimer's disease (AD) than the general population. Early recognition and intervention before the onset of clinical symptoms could potentially avert/delay the long-term consequences of these diseases. Given that AD is thought to have a long pre-clinical incubation period, the aim of the current research was to determine whether former NFL players show evidence of incipient dementia in their structural imaging before diagnosis of AD. To identify neuroimaging markers of AD, against which former NFL players would be compared, we conducted a whole-brain volumetric analysis using a cohort of AD patients (ADNI clinical database) to produce a set of brain regions demonstrating sensitivity to early AD pathology (i.e., the "AD fingerprint"). A group of 46 former NFL players' brain magnetic resonance images were then interrogated using the AD fingerprint, that is, the former NFL subjects were compared volumetrically to AD patients using a T1-weighted magnetization-prepared rapid gradient echo sequence. The FreeSurfer image analysis suite (version 6.0) was used to obtain volumetric and cortical thickness data. The Automated Neuropsychological Assessment Metric-Version 4 was used to assess current cognitive functioning. A total of 55 brain regions demonstrated significant atrophy or ex vacuo dilatation bilaterally in AD patients versus controls. Of the 46 former NFL players, 41% demonstrated a greater than expected number of atrophied/dilated AD regions compared with age-matched controls, presumably reflecting AD pathology.
Competing Interests: No competing financial interests exist.
(© Vijaykumar M. Baragi et al., 2022; Published by Mary Ann Liebert, Inc.)
References: J Neuropathol Exp Neurol. 2009 Jul;68(7):709-35. (PMID: 19535999)
J Neurotrauma. 2022 Apr;39(7-8):436-457. (PMID: 35057637)
Neuron. 2020 Sep 9;107(5):821-835.e12. (PMID: 32603655)
Acta Neuropathol. 2019 Nov;138(5):729-749. (PMID: 31392412)
JAMA Neurol. 2013 Mar 1;70(3):326-35. (PMID: 23303193)
Neural Plast. 2010;2010:108190. (PMID: 21331296)
Gen Psychiatr. 2019 Apr 16;32(2):e100005. (PMID: 31179429)
Brain. 2013 Jan;136(Pt 1):43-64. (PMID: 23208308)
Alzheimers Res Ther. 2013 Jan 09;5(1):1. (PMID: 23302773)
Mol Neurobiol. 2000 Aug-Dec;22(1-3):11-20. (PMID: 11414274)
J Alzheimers Dis. 2015;47(4):985-93. (PMID: 26401777)
Neurology. 1997 Sep;49(3):786-94. (PMID: 9305341)
Neurology. 2000 May 9;54(9):1760-7. (PMID: 10802781)
Childs Nerv Syst. 2002 Aug;18(8):386-404. (PMID: 12192499)
Front Aging Neurosci. 2017 Mar 07;9:38. (PMID: 28326033)
Arch Clin Neuropsychol. 2005 May;20(3):403-8. (PMID: 15797175)
AJNR Am J Neuroradiol. 1999 Jan;20(1):139-44. (PMID: 9974069)
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4703-7. (PMID: 11930016)
Front Neurol. 2019 May 24;10:538. (PMID: 31178818)
Neuroimage. 2017 Jul 15;155:370-382. (PMID: 28479476)
Brain Imaging Behav. 2015 Jun;9(2):190-203. (PMID: 24557591)
Neurosci Biobehav Rev. 2012 May;36(5):1376-81. (PMID: 22390915)
NeuroRehabilitation. 2012;31(3):261-79. (PMID: 23093454)
Trends Cogn Sci. 2003 Jul;7(7):313-319. (PMID: 12860190)
Alzheimers Dement (Amst). 2018 Aug 10;10:629-637. (PMID: 30456290)
Arch Neurol. 2007 Jan;64(1):108-15. (PMID: 17210817)
Neuroimage. 1999 Feb;9(2):179-94. (PMID: 9931268)
J Head Trauma Rehabil. 2010 Jul-Aug;25(4):267-82. (PMID: 20611045)
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11050-5. (PMID: 10984517)
Hum Brain Mapp. 2009 Oct;30(10):3238-53. (PMID: 19277975)
Neuroimage. 2006 Jul 1;31(3):968-80. (PMID: 16530430)
Lancet Neurol. 2002 May;1(1):13-21. (PMID: 12849541)
Cereb Cortex. 2004 Jan;14(1):11-22. (PMID: 14654453)
Ann Neurol. 2020 Jan;87(1):116-131. (PMID: 31589352)
Sci Rep. 2018 Jul 26;8(1):11258. (PMID: 30050078)
Front Cell Neurosci. 2014 Mar 31;8:95. (PMID: 24744700)
Nat Rev Neurol. 2013 Apr;9(4):222-30. (PMID: 23478462)
AJNR Am J Neuroradiol. 1994 May;15(5):929-37. (PMID: 8059663)
Med Sci Sports Exerc. 2007 Jun;39(6):903-9. (PMID: 17545878)
Brain. 2014 Apr;137(Pt 4):1241-53. (PMID: 24523434)
J Neurol Neurosurg Psychiatry. 1997 Aug;63(2):214-21. (PMID: 9285461)
Neurobiol Aging. 2014 Sep;35(9):2039-45. (PMID: 24684788)
Neuroimage. 2020 Sep;218:116932. (PMID: 32416226)
Brain Commun. 2021 Jul 16;3(3):fcab158. (PMID: 34458729)
Front Neurol. 2017 Aug 15;8:399. (PMID: 28861033)
AJR Am J Roentgenol. 2017 Mar;208(3):617-623. (PMID: 28075620)
Hippocampus. 2009 Jun;19(6):549-57. (PMID: 19405131)
Neurobiol Dis. 2015 Feb;74:58-65. (PMID: 25447235)
Metabolism. 2019 Nov;100S:153943. (PMID: 31610856)
J Neurotrauma. 2015 Feb 15;32(4):209-20. (PMID: 25192426)
Acta Radiol. 2012 Apr 1;53(3):318-23. (PMID: 22371624)
Neuron. 2002 Jan 31;33(3):341-55. (PMID: 11832223)
J Comput Assist Tomogr. 2009 Jan-Feb;33(1):73-8. (PMID: 19188789)
Neurology. 2001 Jul 24;57(2):216-25. (PMID: 11468305)
Brain Imaging Behav. 2012 Jun;6(2):137-92. (PMID: 22438191)
Psychiatry Res. 2011 Oct 31;194(1):7-13. (PMID: 21920712)
Neurosurgery. 2005 Oct;57(4):719-26; discussion 719-26. (PMID: 16239884)
Radiology. 2012 May;263(2):344-61. (PMID: 22517954)
Hum Brain Mapp. 2010 Sep;31(9):1339-47. (PMID: 20839293)
Brain Res Bull. 2018 Mar;137:91-97. (PMID: 29174731)
Arch Clin Neuropsychol. 2007 Feb;22 Suppl 1:S101-14. (PMID: 17118625)
J Neurotrauma. 2007 Mar;24(3):446-59. (PMID: 17402851)
Neuroimage. 1999 Feb;9(2):195-207. (PMID: 9931269)
J Int Neuropsychol Soc. 2006 Sep;12(5):707-35. (PMID: 16961952)
Brain. 2009 Aug;132(Pt 8):2048-57. (PMID: 19460794)
Front Hum Neurosci. 2013 May 24;7:222. (PMID: 23745112)
Neuroimage. 2004 Jul;22(3):1060-75. (PMID: 15219578)
فهرسة مساهمة: Keywords: Alzheimer's disease; NFL players; neuroimaging markers
تواريخ الأحداث: Date Created: 20221007 Latest Revision: 20221009
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9531889
DOI: 10.1089/neur.2022.0020
PMID: 36204386
قاعدة البيانات: MEDLINE
الوصف
تدمد:2689-288X
DOI:10.1089/neur.2022.0020